Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growthJyoti Patel, Vincent C.O. Njar|British Journal of Cancer|2007Cited by 40
Simultaneous targeting of androgen receptor (AR) and MAPK-interacting kinases (MNKs) by novel retinamides inhibits growth of human prostate cancer cell linesVidya P. Ramamurthy, Vincent C.O. Njar|Oncotarget|2014Cited by 25
Targeted Degradation of Androgen Receptor by VNPP433-3β in Castration-Resistant Prostate Cancer Cells Implicates Interaction with E3 Ligase MDM2 Resulting in Ubiquitin-Proteasomal DegradationElizabeth Thomas, Vincent C.O. Njar|Cancers|2023Cited by 17
Novel AR/AR-V7 and Mnk1/2 Degrader, VNPP433-3β: Molecular Mechanisms of Action and Efficacy in AR-Overexpressing Castration Resistant Prostate Cancer In Vitro and In Vivo ModelsElizabeth Thomas, Vincent C.O. Njar|Cells|2022Cited by 15
Salinization Dramatically Enhance the Anti-Prostate Cancer Efficacies of AR/AR-V7 and Mnk1/2 Molecular Glue Degraders, Galeterone and VNPP433-3β Which Outperform Docetaxel and Enzalutamide in CRPC CWR22Rv1 Xenograft Mouse ModelRetheesh S. Thankan, Vincent C.O. Njar|Bioorganic Chemistry|2023Cited by 11